Hastatoside attenuatescarbon tetrachloride-induced liver fibrosis by targeting glycogen synthase kinase-3β.

[1]  Jing Liu,et al.  Moringa oleifera Lam. seed extract protects kidney function in rats with diabetic nephropathy by increasing GSK-3β activity and activating the Nrf2/HO-1 pathway. , 2021, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[2]  Qiao Li,et al.  TRIB3‒GSK-3β interaction promotes lung fibrosis and serves as a potential therapeutic target , 2021, Acta pharmaceutica Sinica. B.

[3]  L. Dworkin,et al.  Permissive effect of GSK3β on profibrogenic plasticity of renal tubular cells in progressive chronic kidney disease , 2021, Cell Death & Disease.

[4]  R. Gümüştakım,et al.  TCM use in pregnant women and nursing mothers: A study from Turkey. , 2020, Complementary therapies in clinical practice.

[5]  A. Al-Mokaddem,et al.  Dimethyl fumarate protects against intestinal ischemia/reperfusion lesion: Participation of Nrf2/HO-1, GSK-3β and Wnt/β-catenin pathway. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[6]  Zhenlong Xin,et al.  Glycogen synthase kinase-3β: a promising candidate in the fight against fibrosis , 2020, Theranostics.

[7]  A. Szopa,et al.  Verbena officinalis (Common Vervain) – A Review on the Investigations of This Medicinally Important Plant Species , 2020, Planta Medica.

[8]  Jing-Jue Yuan,et al.  MicroRNA-99b-3p promotes angiotensin II-induced cardiac fibrosis in mice by targeting GSK-3β , 2020, Acta Pharmacologica Sinica.

[9]  Wei Li,et al.  Ginsenoside Rg3 promotes regression from hepatic fibrosis through reducing inflammation-mediated autophagy signaling pathway , 2020, Cell Death & Disease.

[10]  D. Brenner,et al.  Mechanisms of liver fibrosis and its role in liver cancer , 2020, Experimental biology and medicine.

[11]  Y. Inagaki,et al.  A Deactivation Factor of Fibrogenic Hepatic Stellate Cells Induces Regression of Liver Fibrosis in Mice , 2020, Hepatology.

[12]  W. Kong,et al.  PSMP/MSMP promotes hepatic fibrosis through CCR2 and represents a novel therapeutic target. , 2019, Journal of hepatology.

[13]  N. Liang,et al.  NPAS2 Contributes to Liver Fibrosis by Direct Transcriptional Activation of Hes1 in Hepatic Stellate Cells , 2019, Molecular Therapy: Nucleic Acids.

[14]  S. Thorpe,et al.  Retinoic Acid Receptor‐β Is Downregulated in Hepatocellular Carcinoma and Cirrhosis and Its Expression Inhibits Myosin‐Driven Activation and Durotaxis in Hepatic Stellate Cells , 2018, Hepatology.

[15]  Yan Jin,et al.  Alkaline Phosphatase Controls Lineage Switching of Mesenchymal Stem Cells by Regulating the LRP6/GSK3β Complex in Hypophosphatasia , 2018, Theranostics.

[16]  R. Clarke,et al.  Diabetes, Plasma Glucose, and Incidence of Fatty Liver, Cirrhosis, and Liver Cancer: A Prospective Study of 0.5 Million People , 2018, Hepatology.

[17]  Q. Xia,et al.  Inhibition of GSK‐3β induces AP‐1‐mediated osteopontin expression to promote cholestatic liver fibrosis , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  C. Ho,et al.  The Bioactive Extract of Pinnigorgia sp. Induces Apoptosis of Hepatic Stellate Cells via ROS-ERK/JNK-Caspase-3 Signaling , 2018, Marine drugs.

[19]  S. Friedman,et al.  Hepatic stellate cells as key target in liver fibrosis. , 2017, Advanced drug delivery reviews.

[20]  T. Force,et al.  Entanglement of GSK-3β, β-catenin and TGF-β1 signaling network to regulate myocardial fibrosis. , 2017, Journal of molecular and cellular cardiology.

[21]  S. Friedman,et al.  Mechanisms of hepatic stellate cell activation , 2017, Nature Reviews Gastroenterology &Hepatology.

[22]  M. Grawish,et al.  Short-term effects of Verbena officinalis Linn decoction on patients suffering from chronic generalized gingivitis: Double-blind randomized controlled multicenter clinical trial. , 2016, Quintessence international.

[23]  J. Woodgett,et al.  The GSK-3 family as therapeutic target for myocardial diseases. , 2015, Circulation research.

[24]  G. Chou,et al.  Two New Iridoids from Verbena officinalis L. , 2014, Molecules.

[25]  S. Friedman,et al.  Hepatic stellate cells and liver fibrosis. , 2013, Comprehensive Physiology.

[26]  Sutian Xu,et al.  Study on in-vivo anti-tumor activity of Verbena officinalis extract. , 2013, African journal of traditional, complementary, and alternative medicines : AJTCAM.

[27]  D. Mann,et al.  Clinical evidence for the regression of liver fibrosis. , 2012, Journal of hepatology.

[28]  J. Zwerina,et al.  Inhibition of glycogen synthase kinase 3β induces dermal fibrosis by activation of the canonical Wnt pathway , 2011, Annals of the rheumatic diseases.

[29]  D. Ansorena,et al.  Chemical composition, mineral content and antioxidant activity of Verbena officinalis L. , 2011 .

[30]  J. Woodgett,et al.  Glycogen synthase kinase-3 and cancer: good cop, bad cop? , 2008, Cancer cell.

[31]  S. Friedman,et al.  Mechanisms of hepatic fibrogenesis. , 2008, Gastroenterology.

[32]  S. Dooley,et al.  Modulation of transforming growth factor β response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts , 2000, Hepatology.

[33]  M. Hardy.  Herbs of special interest to women. , 2000, Journal of the American Pharmaceutical Association.

[34]  Philip R. Cohen,et al.  Further evidence that the inhibition of glycogen synthase kinase‐3β by IGF‐1 is mediated by PDK1/PKB‐induced phosphorylation of Ser‐9 and not by dephosphorylation of Tyr‐216 , 1997, FEBS letters.